Clinical trial NCT04693416: SMART Trial: Intrapersonal and Interpersonal Stigma Reduction
Official title: SMART Trial: Reducing Stigma Towards Opioid Use Disorder on the Intrapersonal and Interpersonal Levels
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE2
Conditions: Stigma, Social
Opioid Use
Opioid-use Disorder
Substance Use Disorders
Keywords: opioid use disorder
substance use disorder
stigma
Lead sponsor: University of Tennessee
Sponsor class: OTHER
Collaborators: name: National Center for Complementary and Integrative Health (NCCIH)
name: National Institutes of Health (NIH)
First posted: 2021-01-05
Enrollment: 71
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: The goal of this project is to develop a multicomponent stigma reduction intervention to address intrapersonal (individual) stigma regarding Opioid Use Disorder (OUD). The intervention will address this cost/benefit evaluation among individuals known to face intersecting stigma of OUD and African American race, with treatment elements chosen explicitly to increase the value of treatment using salient forms of reward, and to ease perceived costs through explicit services in an effort to encourage the occurrence of the first treatment visit for OUD.


Eligibility criteria: Inclusion Criteria:

* 18 years of age or older
* Identify as African American, Black, or mixed race
* Identify as someone with a substance use disorder who is not currently in treatment OR a support person of someone enrolled
* Access to a telephone for follow-up assessment
* Reside in the Memphis, TN area

Exclusion Criteria:

* Unable to understand consent procedures

Primary outcomes:
measure: Enacted Stigma (Intrapersonal)
timeFrame: Immediately before and 2-weeks post-intervention delivery
measure: Anticipated Stigma (Intrapersonal)
timeFrame: Immediately before and 2-weeks post-intervention delivery
measure: Internalized Stigma (Intrapersonal)
timeFrame: Immediately before and 2-weeks post-intervention delivery
measure: Exposure to Drug Users Index Score
timeFrame: Pre/post intervention (week 0)
measure: Drug Use Stigmatization Scale Score
timeFrame: Pre/post intervention (week 0: post-test immediately followed intervention)
measure: Stigma of Drug Users Scale Score
timeFrame: Pre/post intervention (week 0: post-test immediately followed intervention)
Secondary outcomes:
measure: Engagement in Treatment
timeFrame: 2-weeks post-intervention
Other outcomes:
Locations:
city: Memphis
country: United States
facility: University of Tennessee Health Science Center
state: Tennessee
Study officials:
affiliation: University of Tennessee
name: Karen J Derefinko, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Smith LR, Earnshaw VA, Copenhaver MM, Cunningham CO. Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations. Drug Alcohol Depend. 2016 May 1;162:34-43. doi: 10.1016/j.drugalcdep.2016.02.019. Epub 2016 Feb 26.
citation: Palamar JJ. An examination of beliefs and opinions about drug use in relation to personal stigmatization towards drug users. J Psychoactive Drugs. 2013 Nov-Dec;45(5):367-73. doi: 10.1080/02791072.2013.843044.
citation: Palamar JJ, Kiang MV, Halkitis PN. Development and psychometric evaluation of scales that assess stigma associated with illicit drug users. Subst Use Misuse. 2011;46(12):1457-67. doi: 10.3109/10826084.2011.596606. Epub 2011 Jul 18.